Home > Boards > US Listed > Biotechs > Cel-Sci (CVM)

Fosco likes April for data

Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (1) | Next 10 | Previous | Next
lightrock Member Profile
Member Level 
Followed By 23
Posts 3,575
Boards Moderated 0
Alias Born 10/15/16
160x600 placeholder
CEL-SCI Corporation Reports Third Quarter Fiscal 2021 Financial Results Business Wire - 8/16/2021 9:00:00 AM
Quarterly Report (10-q) Edgar (US Regulatory) - 8/13/2021 4:19:36 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 7/7/2021 3:25:29 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 7/7/2021 10:51:52 AM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 7/7/2021 10:49:10 AM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 7/7/2021 10:45:24 AM
CEL-SCI says analysis of successful study arm was pre-specified in protocol Seeking Alpha - 7/7/2021 9:48:00 AM
CEL-SCI Corporation Issues Letter to Shareholders Business Wire - 7/7/2021 8:00:00 AM
CEL-SCI extends gains despite discussion on cancer trial Seeking Alpha - 7/2/2021 11:53:24 AM
Discussion of Results of CEL-SCI’s Phase 3 Trial Is Now Available Business Wire - 7/2/2021 11:20:00 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 7/2/2021 6:01:17 AM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 7/1/2021 9:13:04 AM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 7/1/2021 9:06:14 AM
Ocuphire Pharma, Predictive Oncology leads healthcare gainers; Altimmune, electroCore among major losers Seeking Alpha - 6/30/2021 11:03:36 AM
CEL-SCI to further discuss late-stage Multikine data in head and neck cancer Seeking Alpha - 6/30/2021 10:59:10 AM
CEL-SCI to Conduct Investor Call Regarding Phase 3 Results Following Annual Shareholder Meeting on July 1, 2021 Business Wire - 6/30/2021 9:00:00 AM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 6/29/2021 10:55:13 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 6/29/2021 8:30:14 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 6/28/2021 4:35:17 PM
CEL-SCI plummets 43% after phase 3 immunotherapy data misses primary endpoint Seeking Alpha - 6/28/2021 11:43:58 AM
CEL-SCI’s Multikine® Immunotherapy Produces Significant 14.1% 5-Year Survival Benefit (62.7% Vs 48.6%) in the Group Receiv... Business Wire - 6/28/2021 9:20:00 AM
CEL-SCI Corporation Invites Participants to Pre-Submit Questions for Annual Shareholder Meeting Business Wire - 6/25/2021 8:30:00 AM
CEL-SCI Announces the Closing of $31.7 Million Bought Deal Offering Business Wire - 6/11/2021 11:49:00 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 6/9/2021 4:09:46 PM
Prospectus Filed Pursuant to Rule 424(b)(5) (424b5) Edgar (US Regulatory) - 6/9/2021 4:08:50 PM
lightrock Member Level  Wednesday, 03/31/21 09:00:47 PM
Re: PlanTrader post# 36601
Post # of 40526 
Fosco likes April for data

I like July

I was poking him in the ribs with a smiley face

Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (1) | Next 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist
Consent Preferences